Harvard chemist teases out why drugs work (or don’t)

Assistant Professor Brian Liau of the Chemistry and Chemical Biology Department has answered the question of why some new drugs for acute myeloid leukemia don’t work by combining CRISPR gene editing with small-molecule inhibitor treatments in a technique he calls CRISPR-suppressor scanning.

Caitlin McDermott-Murphy | May 6, 2019 | harvard
~7 mins   

Tags: science-technology acute-myeloid-leukemia aml brian-liau chemistry chemistry-and-chemical-biology crispr leukemia nature-chemical-biology

Page 1 of 1